Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-26T21:04:32.664Z Has data issue: false hasContentIssue false
  • English
  • Français

On the Genetic Etiology of Scurvy

Published online by Cambridge University Press:  01 August 2014

Irwin Stone
Irwin Stone*
Affiliation:
Staten Island, New York
*
208 Winchester Ave., Staten Island, N. Y. 10312, U.S.A.

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Scurvy, now regarded as a nutritional disorder due to the lack of the trace food constituent, vitamin C, is shown to be the end result of a typical genetic disease. This genetic disease syndrome has been named Hypoascorbemia. Its primary cause is the hereditary lack of — or defect in — the gene controlling the synthesis of the enzyme, L-gulonolactone oxidase. This is a mammalian liver enzyme, the last one in the series for converting glucose into ascorbic acid. Man is one of the few mammals that lacks this enzyme and hence is unable to sythesize his own ascorbic acid. The gene defect occurred during the course of evolution by a conditional lethal mutation. The replacement of the present vitamin C theory regarding the etiology of scurvy by this genetic concept gives important new viewpoints to the quantitative aspects of ascorbic acid in human physiology and also provides new rationales for the use of high levels of ascorbic acid in normal physiology and in the therapy of clinical entities other than scurvy.

Type
Research Article
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 15 , Issue 4 , September 1966 , pp. 345 - 350
Copyright
Copyright © The International Society for Twin Studies 1966

References

Bourne, G. H. (1944). Records in the older literature of tissue changes in Scurvy. Proc. Royal Soc. Med., 37: 512–516.Google Scholar
Bourne, G. H. (1949). Vitamin C and immunity. Brit. J. Nutrit., 2: 341–346.Google Scholar
Burns, J. J. (1959). Biosynthesis of L-ascorbic acid; basic defect in Scurvy. Amer. J. Med., 26: 740–748.Google Scholar
Chatterjee, I. B. el al. (1961). Aspects of ascorbic acid biosynthesis in animals. Ann. N. Y. Acad. Sci., 92: Art. 1, 36–55.CrossRefGoogle ScholarPubMed
Conney, A. H. et al. (1961). Metabolic interactions between ascorbic acid and drugs. Ann. N. Y. Acad. Sci., 92: 115–127.Google Scholar
Ebbell, B. (1938). Alt Aegyptische Bezeichnungen fur Krankheiten und Symptoms. Oslo.Google Scholar
Garrod, A. E. (1908). Inborn errors of metabolism. Lancet., II: 1–7, 73–79, 142–148, 214–220.Google Scholar
Grollman, A. P., Lehninger, A. L. (1957). Enzymatic synthesis of L-ascorbic acid in different animal species. Arch. Biochem., 69: 458–467.Google Scholar
Glueoksohn-Waelsch, S. (1963). Lethal genes and analysis of differentiation. Science., 142: 1269–1276.Google Scholar
Hirsch, A. (1885). Handbook of Geographical and Historical Pathology. Vol. II. The New Sydenham Society, London.Google Scholar
Holst, A., Frölich, T. (1907). Experimental studies relating to ship Beri-beri and Scurvy. II. On the etiology of scurvy. J. Hyg., 7: 634–671.Google Scholar
Salomon, L. L., Stubbs, D. W. (1961). Some aspects of the metabolism of ascorbic acid in rats. Ann. N. Y. Acad. Sci., 92: Art. 1, 128–140.Google Scholar
Stone, I. (1965). Studies of a mammalian enzyme system for producing evolutionary evidence on man. Amer. J. Phys. Anthrop., 23: 83–86.Google Scholar
Stone, I. In Preparation. The Application of Modern Concepts of Ascorbic Acid to Health and Therapy.Google Scholar